Literature DB >> 30190986

Contrast-enhanced ultrasound in liver cancer.

Simona Leoni1, Ilaria Serio1, Anna Pecorelli1, Sara Marinelli1, Luigi Bolondi1.   

Abstract

Contrast-enhanced ultrasound (CEUS) is a sure, noninvasive, repeatable imaging technique widely used in the characterization of benign and malignant liver lesions. The European Federation of Societies for Ultrasound in Medicine and Biology guidelines suggest the typical CEUS features of liver lesions as criteria for the noninvasive diagnosis in cirrhotic and not-cirrhotic patients. The clinical application of CEUS in the liver study is summarized in this review; the contrast-enhanced patterns of the most frequent liver lesions are described (hepatocellular and cholangiocellular carcinoma, liver metastases, hemangioma, focal nodular hyperplasia, adenoma). The role of this imaging technique in the diagnostic algorithm of liver malignancy is illustrated and the CEUS application in hepatologic and oncological settings is depicted.

Entities:  

Keywords:  cholangiocellular carcinoma; contrast agents; hepatocellular carcinoma; liver lesions; liver metastases; ultrasound

Year:  2015        PMID: 30190986      PMCID: PMC6095330          DOI: 10.2217/hep.14.25

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  51 in total

1.  Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.

Authors:  D Strobel; T Bernatik; W Blank; A Schuler; C Greis; C F Dietrich; K Seitz
Journal:  Ultraschall Med       Date:  2011-12-09       Impact factor: 6.548

2.  The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

Authors:  Fabio Piscaglia; Luigi Bolondi
Journal:  Ultrasound Med Biol       Date:  2006-09       Impact factor: 2.998

3.  The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses.

Authors:  Kevin Wei; Sharon L Mulvagh; Lisa Carson; Ravin Davidoff; Ruvin Gabriel; Richard A Grimm; Stephanie Wilson; Lorrie Fane; Charles A Herzog; William A Zoghbi; Rhonda Taylor; Michael Farrar; Farooq A Chaudhry; Thomas R Porter; Waleed Irani; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2008-10-10       Impact factor: 5.251

4.  Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?

Authors:  S Leoni; F Piscaglia; A Granito; A Borghi; M Galassi; S Marinelli; E Terzi; L Bolondi
Journal:  Ultraschall Med       Date:  2013-04-24       Impact factor: 6.548

5.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Authors:  Ramón Vilana; Alejandro Forner; Luis Bianchi; Angeles García-Criado; Jordi Rimola; Carlos Rodríguez de Lope; María Reig; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.

Authors:  Bobby Bhartia; Janice Ward; J Ashley Guthrie; Philip J Robinson
Journal:  AJR Am J Roentgenol       Date:  2003-03       Impact factor: 3.959

7.  The contribution of contrast enhanced ultrasound for the characterization of benign liver lesions in clinical practice - a monocentric experience.

Authors:  Alina Martie; Simona Bota; Ioan Sporea; Roxana Sirli; Alina Popescu; Mirela Danila
Journal:  Med Ultrason       Date:  2012-12       Impact factor: 1.611

8.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging.

Authors:  Michele Di Martino; Gianmaria De Filippis; Adriano De Santis; Daniel Geiger; Maurizio Del Monte; Concetta Valentina Lombardo; Massimo Rossi; Stefano Ginanni Corradini; Gianluca Mennini; Carlo Catalano
Journal:  Eur Radiol       Date:  2012-11-18       Impact factor: 5.315

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  2 in total

1.  Impact of contrast ultrasound diagnosis for patients with liver cancer.

Authors:  Hong-Bin Guo; Jun-Hu Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

2.  Hepatocellular Carcinoma Automatic Diagnosis within CEUS and B-Mode Ultrasound Images Using Advanced Machine Learning Methods.

Authors:  Delia Mitrea; Radu Badea; Paulina Mitrea; Stelian Brad; Sergiu Nedevschi
Journal:  Sensors (Basel)       Date:  2021-03-21       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.